2-aminobicyclo(2,2,1)heptane-2-carboxylic acid has been researched along with calmidazolium in 1 studies
Studies (2-aminobicyclo(2,2,1)heptane-2-carboxylic acid) | Trials (2-aminobicyclo(2,2,1)heptane-2-carboxylic acid) | Recent Studies (post-2010) (2-aminobicyclo(2,2,1)heptane-2-carboxylic acid) | Studies (calmidazolium) | Trials (calmidazolium) | Recent Studies (post-2010) (calmidazolium) |
---|---|---|---|---|---|
166 | 0 | 34 | 550 | 0 | 39 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sampaio-Maia, B; Soares-Da-Silva, P | 1 |
1 other study(ies) available for 2-aminobicyclo(2,2,1)heptane-2-carboxylic acid and calmidazolium
Article | Year |
---|---|
Inhibition of calcium-independent luminal uptake of L-dopa by calmodulin antagonists in immortalized rat capillary cerebral endothelial cells.
Topics: Amino Acids, Cyclic; Aminoisobutyric Acids; Animals; Biological Transport; Calcium Channels, L-Type; Calmodulin; Cell Line; Cell Survival; Cyclic AMP-Dependent Protein Kinases; Cyclic GMP-Dependent Protein Kinases; Endothelium, Vascular; Enzyme Inhibitors; Hydrogen-Ion Concentration; Imidazoles; Inhibitory Concentration 50; Levodopa; Protein Kinase C; Protein-Tyrosine Kinases; Rats; Signal Transduction; Sodium; Telencephalon; Time Factors; Trifluoperazine | 2001 |